Answer
Do not stop without a specialist plan. Severe return of multiple-sclerosis activity has occurred after withdrawal, and switching treatment requires consideration of lingering immune effects.
Sources for this answer
- Fingolimod Olpha 0.5 mg hard capsules — Current selected SmPCemc · Summary of Product Characteristics
- Fingolimod — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.